XRCC3 C18067T Polymorphism Contributes a Decreased Risk to Both Basal Cell Carcinoma and Squamous Cell Carcinoma: Evidence from a Meta-Analysis
Figure 7
Sensitive analysis of XRCC3 C18067T polymorphism and skin cancer risk (recessive model TT versus . TC/CC).